Disclosures related to prescription drugs.
Summary
Requires certain pharmacists or pharmacies to provide the amount of the national average drug acquisition cost for a generic drug on the written materials provided to an individual at the point of sale of the generic drug.
Bill status
passed
3 of 5 stages cleared
Introduction
Jan 2026
Committee Review
Jan 2026
Senate Passage
Jan 2026
House Passage
Governor
Introduced Jan 5, 2026
Last action Jan 28, 2026
Maddy AI version diff · 2 comparisons
What changed between versions
Engrossed Senate Bill (H)
→
Senate Bill (S)
·
3 edits
MINOR
The bill version was updated from SB 157.2 to SB 157.1, with the reprint date changed from January 23, 2026 to January 16, 2026. A significant policy change was made to remove an exemption that previously excluded hospitals, federally qualified health centers, and certain health facilities from the requirement to provide national average drug acquisition costs for generic drugs. This means these healthcare providers are now subject to the same disclosure requirements as pharmacists and pharmacies.
Scope change
The bill's scope was expanded to include hospitals, federally qualified health centers, and health facilities licensed under IC 16-28, which were previously exempt from the drug cost disclosure requirements.
ELIGIBILITY
Removed an exemption clause that previously excluded hospitals, federally qualified health centers, and certain health facilities from the drug cost disclosure requirements.
REQUIREMENT
Updated the language to require all pharmacists and pharmacies to provide national average drug acquisition costs for generic drugs, without the previous exceptions for certain healthcare facilities.
TECHNICAL
Changed the bill number from SB 157.2 to SB 157.1 and updated reprint dates from January 23, 2026 to January 16, 2026.
Floor votes · Senate Jan 26, 2026
How they voted
44–0
Passed · 4 other
Total votes 48
Jan 26, 2026
D
Democratic9
77% Yea
R
Republican39
94% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
13
Key actions
3
Committee
1
Amendments
1
Jan 26, 2026
Upper · Passed
Third reading: passed; Roll Call 72: yeas 44, nays 0
upper
Jan 22, 2026
Upper · Passed
Amendment #1 (Bohacek) prevailed; voice vote
upper
Jan 15, 2026
Upper · Passed
Committee report: amend do pass, adopted
upper
3 primary · 3 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 157
Scope: IN
Hi! I can help you understand SB 157. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline